Clinical trial
A 12-month Open-label Randomized Controlled Trial to Evaluate Sayana® Press Suitability for at Home Subcutaneous Self-injection Procedures in Adult Women
NCT02293694 is registered in ClinicalTrials.gov with FHI 360 as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 12-month Open-label Randomized Controlled Trial to Evaluate Sayana® Press Suitability for at Home Subcutaneous Self-injection Procedures in Adult Women
- Lead sponsor
- FHI 360
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 17, 2015
- Completion date
- August 30, 2017
- Enrollment
- 735 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
contraception